On Tuesday, Energen Corporation (NYSE:EGN)’s shares declined -0.09% to $53.53.
The Board of Directors of Energen Corporation (EGN) declared a quarterly cash dividend of 2 cents per share payable September 1, 2015, to shareholders of record on August 14, 2015.
Energen Corporation, through its partner Energen Resources Corporation, explores for, develops, and produces oil, natural gas, and natural gas liquids in the United States. As of December 31, 2014, the company had about 372.7 million barrels of oil equivalent reserves located in the Permian Basin in west Texas, and the San Juan Basin in New Mexico and Colorado. Energen Corporation was founded in 1929 and is headquartered in Birmingham, Alabama.
Highwoods Properties Inc (NYSE:HIW)’s shares gained 0.24% to $42.04.
Highwoods Properties (NYSE: HIW) Board of Directors declared a cash dividend of $0.425 per share of common stock for the quarter ended June 30, 2015, which equates to an annual dividend of $1.70 per share. This quarterly dividend is payable on September 9, 2015 to shareholders of record as of August 17, 2015.
The Board also declared a cash dividend of $21.5625 per share of the Company’s 8 5/8% Series A Cumulative Redeemable Preferred Stock. The dividend is payable on August 31, 2015, which is the next regularly planned dividend payment date, to shareholders of record as of August 17, 2015.
Highwoods Properties, Inc. is a real estate investment trust. The trust engages in leasing, administration, development, construction, and other customer-related services for its properties and for third parties. It invests in the real estate markets of United States. The trust’s portfolio comprises office, industrial, and retail properties. Highwoods Properties was founded in 1978 and is based in Raleigh, North Carolina.
At the end of Tuesday’s trade, Cytori Therapeutics Inc (NASDAQ:CYTX)‘s shares dipped -6.55% to $0.411.
Cytori Therapeutics (CYTX) declared its second quarter financial results and offered updates on its corporate activity and clinical development.
Cytori continued to reduce its operating cash burn, spending about $4.8 million in the second quarter 2015, contrast to $9.2 million in Q2 2014. Second quarter 2015 net income allocable to common stockholders was $4.5 million (or a net loss of $8.7 million and $0.06 per share when not taking into account a non-cash charge of $13.1 million related to the change in fair value of warrant liabilities) contrast to $11.8 million (or $0.15 per share) for the same period in 2014. Cytori ended the second quarter of 2015 with $23.8 million of cash and cash equivalents.
Selected Q2 Highlights:
Cytori and Lorem Vascular were granted regulatory clearance for Cytori Celution® System by the State Food and Drug Administration of the People’s Republic of China – April 2015
Cytori received initial purchase order of Celution devices and 1,100 consumable sets from Lorem Vascular, our Chinese Licensee – April 2015
Cytori was granted orphan drug status for treatment of scleroderma in European Union – April 2015
Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy comprising of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices and consumable sets, and other ancillary products for the customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions.
Paramount Group Inc (NYSE:PGRE), ended its Tuesday’s trading session with 0.77% gain, and closed at $18.27.
Paramount Group, Inc. (PGRE) stated results for the quarter ended June 30, 2015.
Second Quarter Highlights:
Stated Core Funds from Operations attributable to Paramount Group, Inc. of $46.3 million, or $0.22 per diluted share, for the quarter ended June 30, 2015, counting $4.7 million, or $0.02 per diluted share, of carried interest from fund investments.
Leased 199,972 square feet at a weighted average initial rent of $71.84 per square foot, of which 138,232 square feet represents second generation space for which the Company achieved positive mark-to-markets of 15.4% on a cash basis and 19.0% on a GAAP basis.
Portfolio leased percentage raised to 94.8% at June 30, 2015, up 20 basis points from March 31, 2015 and 90 basis points from December 31, 2014.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.